Stifel Financial’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Stifel Financial’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-60	Closed	-$7.36K	–	3337
2022 Q4	$7.36K	Hold	60	–	–	﹤0.01%	3275
2022 Q3	$9K	Hold	60	–	–	﹤0.01%	3261
2022 Q2	$11K	Hold	60	–	–	﹤0.01%	3297
2022 Q1	$15K	Hold	60	–	–	﹤0.01%	3351
2021 Q4	$15K	Hold	60	–	–	﹤0.01%	3348
2021 Q3	$20K	Hold	60	–	–	﹤0.01%	3306
2021 Q2	$27K	Hold	60	–	–	﹤0.01%	3290
2021 Q1	$30K	Buy	+60	New	+$26K	﹤0.01%	3182

Other funds holding CANF

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Stifel Financial's CANF Position: Q1 2023 in Review

Stifel Financial sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2023, closing a stake of 60 shares — an estimated $7.36K sold.

Stifel Financial first reported a position in CANF in Q1 2021 and held it in 8 quarters. The position peaked at $30K in Q1 2021. 9 funds tracked by Wall St. Rank hold CANF as of Q1 2023.

Stifel Financial reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Stifel Financial sold 60 Can-Fite BioPharma American Depositary Shares shares in Q1 2023, an estimated $7.36K.
Stifel Financial first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2021 and held it in 8 quarters.
Stifel Financial's Can-Fite BioPharma American Depositary Shares position peaked at $30K in Q1 2021.
9 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2023.

Based on Stifel Financial's 13F filing for Q1 2023, filed 12 May 2023.